MARK A SR PRYGOCKI
CIK 1257544 · President · last filed 2026-06-09
MARK A SR PRYGOCKI is a President who has filed 42 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for VRCA, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$5.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.86M
4
42
-$5.67M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRCA | Director | — | $5.73 | — | $0 | 10 | 2026-06-09 |
| Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Director | 5,766 | $0.01 | $78 | $0 | 2 | 2022-06-09 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | — | $3.65 | — | $0 | 2 | 2016-05-09 |
| MRX | President | 304,453 | $61.96 | $18.86M | -$5.67M | 27 | 2012-04-05 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +1,922 | $0 | EDGAR |
| 2021-12-14 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +3,844 | $0 | EDGAR |
| 2021-06-17 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2020-06-12 | VRCA | Grant (A) | — | $0 | EDGAR |